ProAxsis Transitions to Independent Growth Company to Advance Respiratory Research
A new fundraise will support commercial scale-up and the development of biomarker technology for respiratory disease drug development.
A new fundraise will support commercial scale-up and the development of biomarker technology for respiratory disease drug development.
HHS secretary Robert F Kennedy, Jr signed determinations to end COVID-19 emergency use authorizations for drugs, biological products, and medical devices because the emergency circumstances no longer exist.
On July 1, international organizations aim to increase awareness and research for bronchiectasis to improve patient outcomes and healthcare access.
Michelle Ng Gong succeeds Raed Dweik as president of the American Thoracic Society.
ENA Respiratory received notices of allowance for two US patents covering its innate immune modulators and their application in preventing COPD exacerbations.
Rextovy, a 4 mg naloxone medication, will be available for purchase without a prescription at retail stores and online.
Baxter issued an Urgent Medical Device Correction notice for all Volara System patient circuits to be corrected prior to continued use, according to an FDA alert.